C7r8haaotxaznzeycxqp murigen

Murigenics

ic 9.5/10 Overall Rating No Reviews Yet
ic 9 Orders Completed
vallejo, California, US

About Murigenics

MuriGenics offers and delivers robust preclinical in-vivo and in-vitro contract drug discovery and development services, supported with statistical validation, solid science and project management to companies throughout the United States.

Our growth is driven by repeat customers who recognize that... Show more »

MuriGenics offers and delivers robust preclinical in-vivo and in-vitro contract drug discovery and development services, supported with statistical validation, solid science and project management to companies throughout the United States.

Our growth is driven by repeat customers who recognize that MuriGenics delivers on-time, quality results.

Our lead scientists bring over 50 years of experience and expertise to the table. In the past year, our scientific team has specialized in developing protocols, integrating in-vivo and in-vitro assays for our clients. Such innovation has minimized use of resources while maximizing information obtained from a single study.

We specialize in disease models for oncology, cardiovascular, inflammation and metabolic diseases. Please inquire about any additional models.

Show less

Our Services (28)


ic

Drug Induced Phospholipidosis (PLD) Assay

Price on request
Request a quote for more information about this service.

ic

Xenograft Models

Price on request
  • Syngeneic Tumor Cell Line Models:
    • CT26, MC38, SA1N, LLC, 4T1, A20, Panc02, B16F10
  • Human Tumor Cell Line Model: (many more not included)
    • Prostate: PC3, DU145, LNCaP, 22Rv1
    • Breast: BT474, MCF7, SKBR3, BT 483
    • Colorectal: HT29, SNU C2B, HCT-116
    • Lung: NCI H460, A549, NCI-H2
    • Melanoma: WM115, A375
      -... Show more »
  • Syngeneic Tumor Cell Line Models:
    • CT26, MC38, SA1N, LLC, 4T1, A20, Panc02, B16F10
  • Human Tumor Cell Line Model: (many more not included)
    • Prostate: PC3, DU145, LNCaP, 22Rv1
    • Breast: BT474, MCF7, SKBR3, BT 483
    • Colorectal: HT29, SNU C2B, HCT-116
    • Lung: NCI H460, A549, NCI-H2
    • Melanoma: WM115, A375
    • Ovarian: SK-OV3. OvCAR3
    • Pancreatic: BxPC3
    • Glioblastoma: A172
  • Hematopoietic Tumors:
    • MV-4-11, K562, MMI.S
Show less

ic

ADME/DMPK Studies

Drug Metabolism and Pharmacokinetics
Price on request

Determining the pharmacokinetics (PK) of novel test compounds is essential for approximating efficacy during the drug development and discovery phases. At MuriGenics, we provide a wide-range of murine pharmacokinetic, bioavailability and biodistribution services that can be customized to meet the needs of our clients.

In order... Show more »

Determining the pharmacokinetics (PK) of novel test compounds is essential for approximating efficacy during the drug development and discovery phases. At MuriGenics, we provide a wide-range of murine pharmacokinetic, bioavailability and biodistribution services that can be customized to meet the needs of our clients.

In order to screen for possible gene-compound interactions, MuriGenics provides preclinical pharmacogenetic PK profiling through the use of a variety of strains of rats or mice. In addition, a PK component can be added to a Disease Model study to assess changes within PK parameters during a particular disease state.

As with all of our in vivo services, we guarantee continued communication during on-going studies and will contact you directly with any questions or concerns. This helps to guarantee that any data collected is both biologically and clinically reliable and relevant.

Species

  • Mice (outbred, inbred, genetically engineered strains, contact us for additional information on a specific strain or with questions regarding strains that may express a specific phenotype of interest)
  • Rats (implanted catheters available, inquire about strains)

PK Dose Administration

A compound of interest is delivered via one of several routes. Typically, there are 3-5 animals/dose/group. Some studies may require several concentrations of a particular compound of interest or the use of different formulations and vehicles. Routes of administration available for drug delivery include:

  • Oral
  • Intravenous
  • Intramuscular
  • Intraperitoneal
  • Subcutaneous
  • Topical
  • Intratracheal
  • Slow Infusion
  • Continuous Infusions (Osmotic or syringe pump)

Sampling Time Points

At various time points set forth in the study protocol, blood samples (tissue samples) will be collected and processed. The number of and distance between time points will be dependent upon the compound, the route of administration, and its half-life.

Biliary Pharmacokinetics

Biliary pharmacokinetic studies may be conducted to determine biliary excretion and clearance of test articles.

PK Analysis in Disease Models

Since the pharmacokinetics of a compound may change during disease influencing efficacy, PK studies may be performed in conjunction with Disease Models. Contact us to inquire about adding a PK component to one of our available disease models or to discuss a study idea of your own.

Show less

ic

Cell-Based Assays

Price on request

Cell-based assay development can range from cytotoxic assays, such as apoptosis, to cell proliferation, calcium mobilization, and cell-based immunoassays. Mechanisms of action, including receptor binding, receptor activation, cell signaling, drug internalization and subcellular localization can be delineated in cell-based assays following treatment with your pharmaceuticals.

Cell-based assay development can range from cytotoxic assays, such as apoptosis, to cell proliferation, calcium mobilization, and cell-based immunoassays. Mechanisms of action, including receptor binding, receptor activation, cell signaling, drug internalization and subcellular localization can be delineated in cell-based assays following treatment with your pharmaceuticals.

Show less

ic

Custom Animal Models

Price on request

If the standard animal models or cell-based assays don’t meet your needs, Murigenics will help you develop new models and experimental protocols to suit.

If the standard animal models or cell-based assays don’t meet your needs, Murigenics will help you develop new models and experimental protocols to suit.

Show less

ic

Assay Development

Price on request

Bioassay development encompasses testing of conditioned medium, cell lysates or whole cells in a variety of formats these include ELISA and Luminex immunoassays along with immunohistochemical methods such as flow cytometry.

Additionly, MuriGenics has GxP capabilities through the use of the FlexStation3 system, a multiplatform,... Show more »

Bioassay development encompasses testing of conditioned medium, cell lysates or whole cells in a variety of formats these include ELISA and Luminex immunoassays along with immunohistochemical methods such as flow cytometry.

Additionly, MuriGenics has GxP capabilities through the use of the FlexStation3 system, a multiplatform, high-throughput instrument. This platform has a wide range of applications for cell and bioassays.

  • Cell-Based Assays
  • Immunoassays
  • Additional Capabilities and Instrumentation
Show less

ic

In vitro Toxicity Testing

Price on request

MuriGenics performs a variety of in vitro toxicity screens and assays. Performing in vitro cytotoxicity assays prior to animal testing may be a cheaper alternative for initial drug screens. Since many of these tests require cell-based assays, our experience in cell biology, enables us to analyze cells using molecular and... Show more »

MuriGenics performs a variety of in vitro toxicity screens and assays. Performing in vitro cytotoxicity assays prior to animal testing may be a cheaper alternative for initial drug screens. Since many of these tests require cell-based assays, our experience in cell biology, enables us to analyze cells using molecular and biochemical techniques as well as morphologically.

In Vitro Myelotoxicity

Myelotoxicity is a serious side-effect of many chemotherapeutic and immune-suppressive agents. This condition can lead to serious life-threatening infection and neutropenic sepsis. MuriGenics provides a panel of screens designed to help our clients gain insight into the likelihood and degree to which their compounds may produce myelotoxicity and thus aid them in lead candidate selection. Below is our panel of screens:

  • CFU-GM (Colony Forming Unit Granulocyte Monocyte) for Neutropenia
  • CFU-GEMM (Colony Forming Unit Granulocyte Erythrocyte, Monocyte Megakaryocyte) for Multipotential Cytopenias
  • BFU-e (Busrt Forming Unit Erythroid for Erythropenia)
  • CFU-Mk (Colony Forming Unit Megakaryocyte) for Thrombocytopenia
  • Cytometry
  • Hematopoietic Assays
    • Long Term Cultures (LTCIC) Assays
    • Characterization of Hematopoietic Cells

In Vitro Hepatotoxicity – Rat

Drug-induced hepatic injury is a common reason for the withdrawal of an approved drug. Drug-induced hepatotoxicity ranges from asymptomatic elevation of liver enzymes to fulminant hepatic failure. We perform a series of assay screens that may be utilized throughout the discovery and development phases in conjunction with traditional in vivo methods to aid the client in the selection of a lead compound. Below is a list of assessments that we perform:

  • Morphological Evaluation
  • LDH Leakage
  • MTS
  • Pathology Specific Hepatotoxicity
    • Steatosis
    • Phospholipidosis
  • CYP Inhibition/Induction (Drug/Drug Interactions)
    • bDNA – Luminex xMAP Platform
    • ATPase Assay (Transporters)
Show less

ic

Inflammation Animal Models

Price on request

Allotransplantation

  • Skin Transplantation – Host Immune Response to Foreign Tissue (Murine Allograft)

Airpouch

  • Lipopolysaccharide (LPS)
  • Carrageenan

Contact Hypersensitivity & Delayed-Type Hypersensitivity

  • Dermal 2,4-Dinitro-1-Fluorobenzene (DNFB)
  • Intradermal Methylated-BSA

Dermal

Allotransplantation

  • Skin Transplantation – Host Immune Response to Foreign Tissue (Murine Allograft)

Airpouch

  • Lipopolysaccharide (LPS)
  • Carrageenan

Contact Hypersensitivity & Delayed-Type Hypersensitivity

  • Dermal 2,4-Dinitro-1-Fluorobenzene (DNFB)
  • Intradermal Methylated-BSA

Dermal

  • Dermal Scar Model
  • Skin Inflammation

Hepatitis

  • Non-Lethal LPS/D-GalN Induced Hepatitis (Acute Model)

Inflammatory Bowel Disease (IBD)

  • Dextran Sodium Sulfate in Drinking Water (DSS)
  • Colonic Instillation of Trinitrobenzene Sulfonic Acid (TNBD)

Local Inflammation

  • Carrageenan Injection Hind Paw
  • Passive Cutaneous Analphylaxis (PCA)

Peritonitis

  • Thioglycollate, Mineral Oil, or Pristane-Induced

Pulmonary Inflammation (Lung Injury)

  • Lipopolysaccharide (LPS)
  • Ovalbumin (OVA)

Renal Acute Inflammation

  • Unilateral Ureter Obstruction (UUO)
  • High-Protein Diet (rats)

Sepsis

  • Intraperitoneal Lipopolysaccharide (LPS)
  • Intraperitoneal Staphlococcal Enterotoxin-B (SEB)
Show less

ic

Metabolic Disease Animal Models

Price on request

Obesity, Diabetes and Metabolic Syndrome

  • Dietary
    • C57BL/6J or /6N Mouse Diet-Induced Obesity (DIO)
    • Fructose Diet Sprague Dawley Rat
  • Genetically Modified
    • db/db
    • ob/ob
    • Zucker Fatty Diabetic Rat (ZDF)
    • Zucker Fatty Rat

Renal Failure

  • Goto-Kakizaki (GK) Rats Treated with a High-Salt Diet &... Show more »

Obesity, Diabetes and Metabolic Syndrome

  • Dietary
    • C57BL/6J or /6N Mouse Diet-Induced Obesity (DIO)
    • Fructose Diet Sprague Dawley Rat
  • Genetically Modified
    • db/db
    • ob/ob
    • Zucker Fatty Diabetic Rat (ZDF)
    • Zucker Fatty Rat

Renal Failure

  • Goto-Kakizaki (GK) Rats Treated with a High-Salt Diet & Angiotensin II

Steatosis

  • Atherogenic Diet (Piagen)
  • C57BL/6J High-Fat Diet
  • ob/ob; db/db
  • NON/ShiLtJ High-Fat Diet
  • Dietary Methionine/Choline Deficient
Show less

ic

Infectious Disease Animal Models

Price on request
  • Neutropenic Thigh Model (Cyclophosphamide and IM Bacteria Injection)
  • Superficial Skin Wound Infection Model
  • Neutropenic Thigh Model (Cyclophosphamide and IM Bacteria Injection)
  • Superficial Skin Wound Infection Model
Show less

ic

Gastrointestinal Disease Animal Models

Price on request
  • Intestinal Transit Time of Alimentary Bolus
  • Biliary Secretion by Cannulated Bile Duct (see also Pharmacokinetics)
  • Gastric Emptying of Liquids and Solids
  • Intestinal Transit Time of Alimentary Bolus
  • Biliary Secretion by Cannulated Bile Duct (see also Pharmacokinetics)
  • Gastric Emptying of Liquids and Solids
Show less

ic

CNS/Neurology Animal Models

Price on request
  • Parkinson’s Disease by MPTP Injection (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
  • Behavioral
    • Elevated Plus-Maze
    • Open Field Activity
    • Tail Suspension
    • Startle Response
    • Hang Time
  • Parkinson’s Disease by MPTP Injection (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
  • Behavioral
    • Elevated Plus-Maze
    • Open Field Activity
    • Tail Suspension
    • Startle Response
    • Hang Time
Show less

ic

Cardiovascular Animal Models

Price on request
  • Atherosclerosis: Transgenic and Atherogenic Diet
    • ApoE -/-
    • LDLR-/-
    • sPLA2-trangenic
  • Carotid Artery Ligation (mouse)
  • Hypertension
    • Spontaneously Hypertensive Rat (SHR) Model
    • Angiotensin-2 Infusion
    • High-Salt Diet
  • Restenosis Following Carotid Balloon Angioplasty (rat)
  • Chemically-Induced... Show more »
  • Atherosclerosis: Transgenic and Atherogenic Diet
    • ApoE -/-
    • LDLR-/-
    • sPLA2-trangenic
  • Carotid Artery Ligation (mouse)
  • Hypertension
    • Spontaneously Hypertensive Rat (SHR) Model
    • Angiotensin-2 Infusion
    • High-Salt Diet
  • Restenosis Following Carotid Balloon Angioplasty (rat)
  • Chemically-Induced Carotid Thrombus Formation (rat)
  • Thrombosis
    • Tail Bleeding Time
    • Blood Coagulation Time
Show less

ic

Rheumatoid Arthritis Animal Models

Price on request
  • Collagen Induced Arthritis (CIA)
  • Type-2 Collagen Monoclonal Antibody (mAB) Cocktail
  • Collagen Induced Arthritis (CIA)
  • Type-2 Collagen Monoclonal Antibody (mAB) Cocktail
Show less

ic

Experimental Autoimmune Encephalomyelitis (EAE) Animal Models

Price on request
  • MOG (myelin-oligodendrocyte-glycoprotein) Induced
  • PLP (proteolipid protein) Induced
  • Passive Transfer of Sensitized Lymphoid Cells
  • MOG (myelin-oligodendrocyte-glycoprotein) Induced
  • PLP (proteolipid protein) Induced
  • Passive Transfer of Sensitized Lymphoid Cells
Show less

ic

Diabetes Animal Models

Price on request

Non-Obese Diabetic (NOD Mice)

Non-Obese Diabetic (NOD Mice)

Show less

ic

Metabolic Animal Models

Price on request
Request a quote for more information about this service.

ic

Gastroenterology Animal Models

Price on request
Request a quote for more information about this service.

ic

Oncology Animal Models

Price on request
Request a quote for more information about this service.

ic

Animal Models and Studies

Price on request
Request a quote for more information about this service.

ic

Drug Discovery & Development

Price on request

Drug Discovery & Development Services

Drug Discovery & Development Services

Show less

ic

Cytotoxicity Assays

Price on request

Cytotoxicity Assays Services

Cytotoxicity Assays Services

Show less

ic

Project Management

Price on request
Request a quote for more information about this service.

ic

Biology

Price on request
Request a quote for more information about this service.

ic

Pharmacology & Toxicology

Price on request
Request a quote for more information about this service.

ic

Animal Models of Disease

Price on request
Request a quote for more information about this service.

ic

Toxicology

Price on request
Request a quote for more information about this service.

ic

Immunology Animal Models

Price on request
Request a quote for more information about this service.

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
Missing Avatar

Henry Lopez

President and CSO

Murigenics has not received any reviews.

Murigenics has not received any endorsements.